Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00434694 · ClinicalTrials.gov registry record · NA

A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
300
Enrollment target

NCT00434694: Completed NA study, sponsored by University of Pennsylvania.

NCT00434694 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00434694, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target

Study Summary

This is a study of different techniques for treatment of atrial fibrillation using a procedure called radiofrequency catheter ablation. Atrial fibrillation (called AF) is when the upper chambers of the heart (the atria) beat much faster than the lower chambers, causing the heart to beat less effectively. AF can cause stroke, impaired performance, palpitations, shortness of breath, passing out and other symptoms. Radiofrequency ablation involves placement of catheter/electrode wires into the heart through plastic tubes inserted into veins / arteries in both the groins and the right side of the neck under local anesthesia. Radiofrequency energy is delivered to the areas inside the heart that cause the rapid firing of the atria, causing small lesions or "burns" that destroy the heart tissue where the extra electrical impulses come from. Commonly this area is where the four pulmonary veins (PV) deliver blood from the lungs to the left side of the heart, and the procedure is also referred to as "pulmonary vein isolation" or PVI. This study compares two different strategies for performing the pulmonary vein isolation procedure, and compares the effect using two different types of radiofrequency ablation catheters.

Interventions

  • PROCEDURE Pulmonary Vein Isolation (Radiofrequency Catheter Ablation)

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2003-07
Est. Completion 2006-02
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT00434694

The ClinicalTrials.gov registry entry for NCT00434694 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pulmonary Vein Isolation (Radiofrequency Catheter Ablation) is the first listed.

NCT00434694 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00434694 about?

NCT00434694 is a clinical study titled "A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation". This is a study of different techniques for treatment of atrial fibrillation using a procedure called radiofrequency catheter ablation. Atrial fibrillation (called AF) is when the upper chambers of the heart (the atria) beat much faster than the lower chambers, causing the heart to beat less effecti...

What is the current status of trial NCT00434694?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2003-07. Estimated completion is 2006-02.

What interventions are being tested in trial NCT00434694?

The interventions under investigation include: Pulmonary Vein Isolation (Radiofrequency Catheter Ablation) (PROCEDURE).

Who is sponsoring clinical trial NCT00434694?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.